Cargando…

Evaluation of the role of recombinant activated factor VII (NovoSeven) as a rescue haemostatic therapy in postcardiopulmonary bypass surgical patients

Detalles Bibliográficos
Autores principales:	Chen, Z, Rasiah, V, Dewhurst, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095432/ http://dx.doi.org/10.1186/cc5539

Ejemplares similares

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®))
por: Bartosh, Nicole S, et al.
Publicado: (2013)

Experience of NovoSeven administration in management of coagulopathic bleedings after surgical interventions with extracorporeal circulation
por: Dzybinskaya, E, et al.
Publicado: (2006)

Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven(®)) in obstetrical haemorrhagic shock
por: Sobieszczyk, S, et al.
Publicado: (2003)

Use of NovoSeven(® )in cases with massive bleeding following surgery with extracorporeal circulation
por: Dementieva, I, et al.
Publicado: (2004)

Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven(®)) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial
por: Thabut, D, et al.
Publicado: (2004)

Experience of NovoSeven administration in the management of severe haemorrhage following cardiac surgery of nonhaemophilic patients
por: Michalska, G, et al.
Publicado: (2007)

Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit
por: Bonadona, A, et al.
Publicado: (2002)

Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven(®))
por: Viuff, D., et al.
Publicado: (2008)

Management of Acquired Factor VIII Inhibitors With NovoSeven and Obizur
por: Miatech, Jennifer L, et al.
Publicado: (2021)

A Case of “Anaphylaxis” to NovoSeven in a Hemophiliac Patient
por: Wang, Andy, et al.
Publicado: (2023)

Methylene Blue for Postcardiopulmonary Bypass Vasoplegic Syndrome: A Cohort Study
por: Mazzeffi, Michael, et al.
Publicado: (2017)

Younger age is associated with greater early neurocognitive decline postcardiopulmonary bypass
por: Anderson, Kelsey, et al.
Publicado: (2020)

The use of recombinant factor VIIa as a haemostatic agent in ICU patients
por: Vernikos, P, et al.
Publicado: (2004)

Timely ‘off-label’ use of recombinant activated factor VII (NovoSeven(®)) can help in avoiding hysterectomy in intractable obstetric bleeding complicated with disseminated intravascular coagulation: A case report and review of the literature
por: Burad, Jyoti, et al.
Publicado: (2012)

Treatment of obstetric hemorrhage with recombinant activated factor VII
por: Czuprynski, P, et al.
Publicado: (2009)

Activated recombinant factor VII in management of bleeding in patients with thrombocytopenia
por: Shulutko, E, et al.
Publicado: (2006)

Recombinant activated factor VII: does it really save lives?
por: Edke, U
Publicado: (2009)

Use of recombinant activated factor VII after paediatric cardiac surgery
por: Kharkin, A, et al.
Publicado: (2006)

Safety of activated recombinant factor VII in patients with circulatory assist devices
por: Schneider, AS, et al.
Publicado: (2009)

Successful use of recombinant activated factor VII (eptacog alfa, Novoseven®) in a refractory bleeding during pediatric cardiac surgery: a case report
por: Ishihara, Mariko, et al.
Publicado: (2015)

Guidelines-associated decrease in mortality with recombinant activated factor VII for refractory hemorrhage
por: Schneider, AS, et al.
Publicado: (2009)

Recombinant activated factor VII for the treatment of bleeding in abdominal surgery and cardiac surgery
por: Michalska, G, et al.
Publicado: (2009)

Efficacy of recombinant activated factor VII in the management of severe hemorrhage following cardiac surgery
por: Trecova, N, et al.
Publicado: (2006)

Two years experience with low-dose recombined activated factor VII treatment of non-haemophilic patients
por: Michalska, G, et al.
Publicado: (2006)

Combination of Novoseven and Feiba in Hemophiliac Patients with Inhibitors
por: Malkan, Umit Yavuz, et al.
Publicado: (2018)

Haemostatic activation markers in brain injury for mortality prediction: comparison of blood samples from the jugular bulb and central venous line
por: Baffoun, N, et al.
Publicado: (2007)

Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
por: Rossaint, R, et al.
Publicado: (2006)

Analysis of the off-licence use of recombinant activated factor VII for patients with uncontrolled haemorrhage in a UK tertiary referral hospital
por: Spivey, M, et al.
Publicado: (2009)

Recombinant activated factor VII treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, and efficacy and safety outcomes
por: Liebl, M, et al.
Publicado: (2007)

Cardiopulmonary bypass and recombinant plasminogen activator for treatment of experimental fatal pulmonary embolism
por: Kjærgaard, B, et al.
Publicado: (2007)

Factor VII for intractable bleeding after cardiac surgery
por: Kogan, A, et al.
Publicado: (2007)

Reversing Postcardiopulmonary Bypass Associated Cognitive Dysfunction Using k-Opioid Receptor Agonists to Regulate Microglial Polarization via the NLRP3/Caspase-1 Pathway
por: Song, Pei, et al.
Publicado: (2021)

Retracted: Reversing Postcardiopulmonary Bypass Associated Cognitive Dysfunction Using k-Opioid Receptor Agonists to Regulate Microglial Polarization via the NLRP3/Caspase-1 Pathway
por: Healthcare Engineering, Journal of
Publicado: (2023)

P394: Process evaluation of the sterilization of medical devices and surgical textiles in seven hospitals in Mali and Senegal
por: Traoré, AT, et al.
Publicado: (2013)

The use of activated recombinant coagulation factor VII in patients undergoing major reconstruction surgery for traumatic fracture pelvis or pelvis and acetabulum: a double-blind, randomised, placebo-controlled trial
por: Raobaikady, R, et al.
Publicado: (2005)

Does cardiopulmonary bypass affect the procalcitonin level?
por: Kalay, F, et al.
Publicado: (2005)

Citrate does not Change Viscoelastic Haemostatic Assays after Cardiopulmonary Bypass
por: Kristobak, Benjamin M., et al.
Publicado: (2022)

Endothelial protein C receptor expression after cardiopulmonary bypass in adult cardiac surgical patients
por: Hajek, R, et al.
Publicado: (2010)

Pediatric sarcoidosis: report of seven cases
por: Ricardo, Yépez, et al.
Publicado: (2011)

The Seven Ages of Man: VII. "Sans Everything"
Publicado: (1888)

Cannot write session to /tmp/vufind_sessions/sess_08t0nvgd8c4gfri7nvcocmgstp